All naturally occurring autoantibodies against the NMDA receptor subunit NR1 have pathogenic potential irrespective of epitope and immunoglobulin class. (Q48544513)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	All naturally occurring autoantibodies against the NMDA receptor subunit NR1 have pathogenic potential irrespective of epitope and immunoglobulin class.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27502473%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

All naturally occurring autoantibodies against the NMDA receptor subunit NR1 have pathogenic potential irrespective of epitope and immunoglobulin class (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27502473%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

1 reference

based on heuristic

inferred from title

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27502473%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

Esther Castillo-Gómez

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27502473%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

Barbara Oliveira

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27502473%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27502473%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

Hannelore Ehrenreich

14

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27502473%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

author name string

S Bertrand

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27502473%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

C Klein-Schmidt

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27502473%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

H Pan

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27502473%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

P Zafeiriou

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27502473%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

J Steiner

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27502473%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

R Trippe

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27502473%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

H Prüss

11

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27502473%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

W-H Zimmermann

12

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27502473%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

D Bertrand

13

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27502473%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

M Hollmann

15

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27502473%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

language of work or name

0 references

publication date

9 August 2016

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27502473%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

Molecular Psychiatry

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27502473%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

22

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27502473%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

12

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27502473%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

1776-1784

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27502473%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

copyright license

Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International

9 August 2016

1 reference

April 2022 Public Data File from Crossref

copyright status

0 references

https://scigraph.springernature.com/pub.10.1038/mp.2016.125

0 references

The immunopathogenesis of paraneoplastic neurological syndromes

1 reference

https://api.crossref.org/works/10.1038%2FMP.2016.125

21 January 2018

Losing your nerves? Maybe it's the antibodies

1 reference

https://api.crossref.org/works/10.1038%2FMP.2016.125

21 January 2018

Do neuronal autoantibodies cause psychosis? A neuroimmunological perspective

1 reference

https://api.crossref.org/works/10.1038%2FMP.2016.125

21 January 2018

Autoimmune synaptopathies

1 reference

https://api.crossref.org/works/10.1038%2FMP.2016.125

21 January 2018

Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies

1 reference

https://api.crossref.org/works/10.1038%2FMP.2016.125

21 January 2018

Anti-NMDA-receptor encephalitis: a severe, multistage, treatable disorder presenting with psychosis

1 reference

https://api.crossref.org/works/10.1038%2FMP.2016.125

21 January 2018

Disease-relevant autoantibodies in first episode schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FMP.2016.125

21 January 2018

Increased prevalence of diverse N-methyl-D-aspartate glutamate receptor antibodies in patients with an initial diagnosis of schizophrenia: specific relevance of IgG NR1a antibodies for distinction from N-methyl-D-aspartate glutamate receptor encepha

1 reference

https://api.crossref.org/works/10.1038%2FMP.2016.125

21 January 2018

Neuropsychiatric disease relevance of circulating anti-NMDA receptor autoantibodies depends on blood-brain barrier integrity

1 reference

https://api.crossref.org/works/10.1038%2FMP.2016.125

21 January 2018

Seroprevalence of autoantibodies against brain antigens in health and disease.

1 reference

https://api.crossref.org/works/10.1038%2FMP.2016.125

21 January 2018

Preexisting Serum Autoantibodies Against the NMDAR Subunit NR1 Modulate Evolution of Lesion Size in Acute Ischemic Stroke

1 reference

https://api.crossref.org/works/10.1038%2FMP.2016.125

21 January 2018

Prevalence of N-methyl-D-aspartate receptor autoantibodies in the peripheral blood: healthy control samples revisited.

1 reference

https://api.crossref.org/works/10.1038%2FMP.2016.125

21 January 2018

The brain as immunoprecipitator of serum autoantibodies against N-Methyl-D-aspartate receptor subunit NR1.

1 reference

https://api.crossref.org/works/10.1038%2FMP.2016.125

21 January 2018

Seroprevalence of N-methyl-D-aspartate glutamate receptor (NMDA-R) autoantibodies in aging subjects without neuropsychiatric disorders and in dementia patients.

1 reference

https://api.crossref.org/works/10.1038%2FMP.2016.125

21 January 2018

Apolipoprotein E4 carrier status plus circulating anti-NMDAR1 autoantibodies: association with schizoaffective disorder

1 reference

https://api.crossref.org/works/10.1038%2FMP.2016.125

21 January 2018

Acute mechanisms underlying antibody effects in anti-N-methyl-D-aspartate receptor encephalitis

1 reference

https://api.crossref.org/works/10.1038%2FMP.2016.125

21 January 2018

Modification of cognitive performance in schizophrenia by complexin 2 gene polymorphisms

1 reference

https://api.crossref.org/works/10.1038%2FMP.2016.125

21 January 2018

Comparative study of human-induced pluripotent stem cells derived from bone marrow cells, hair keratinocytes, and skin fibroblasts

1 reference

https://api.crossref.org/works/10.1038%2FMP.2016.125

21 January 2018

Directed differentiation of human pluripotent stem cells to cerebral cortex neurons and neural networks

1 reference

https://api.crossref.org/works/10.1038%2FMP.2016.125

21 January 2018

Fiji: an open-source platform for biological-image analysis

1 reference

https://api.crossref.org/works/10.1038%2FMP.2016.125

21 January 2018

An automated system for intracellular and intranuclear injection.

1 reference

https://api.crossref.org/works/10.1038%2FMP.2016.125

21 January 2018

Site-directed mutagenesis by overlap extension using the polymerase chain reaction

1 reference

https://api.crossref.org/works/10.1038%2FMP.2016.125

21 January 2018

Anti-NMDA receptor encephalitis antibody binding is dependent on amino acid identity of a small region within the GluN1 amino terminal domain.

1 reference

https://api.crossref.org/works/10.1038%2FMP.2016.125

21 January 2018

NMDA-induced neuronal survival is mediated through nuclear factor I-A in mice

1 reference

https://api.crossref.org/works/10.1038%2FMP.2016.125

21 January 2018

Anti-NMDA Receptor Encephalitis in the Polar Bear (Ursus maritimus) Knut

1 reference

https://api.crossref.org/works/10.1038%2FMP.2016.125

21 January 2018

Utility of autoantibodies as biomarkers for diagnosis and staging of neurodegenerative diseases

1 reference

https://api.crossref.org/works/10.1038%2FMP.2016.125

21 January 2018

Brain-reactive antibodies and disease.

1 reference

https://api.crossref.org/works/10.1038%2FMP.2016.125

21 January 2018

Innate and adaptive autoimmunity directed to the central nervous system

1 reference

https://api.crossref.org/works/10.1038%2FMP.2016.125

21 January 2018

High prevalence of NMDA receptor IgA/IgM antibodies in different dementia types

1 reference

https://api.crossref.org/works/10.1038%2FMP.2016.125

21 January 2018

Polyreactive autoantibodies in systemic lupus erythematosus have pathogenic potential

1 reference

https://api.crossref.org/works/10.1038%2FMP.2016.125

21 January 2018

B cell and/or autoantibody deficiency do not prevent neuropsychiatric disease in murine systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1038%2FMP.2016.125

21 January 2018

Blood-brain barrier breakdown in the aging human hippocampus

1 reference

https://api.crossref.org/works/10.1038%2FMP.2016.125

21 January 2018

Myasthenia Gravis: Passive Transfer from Man to Mouse

1 reference

https://pubmed.ncbi.nlm.nih.gov/27502473

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Association of antibodies to the NR1 subunit of N-methyl-D-aspartate receptors with neuropsychiatric systemic lupus erythematosus

1 reference

https://pubmed.ncbi.nlm.nih.gov/27502473

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1038/MP.2016.125

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27502473%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27502473%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48544513&oldid=1851163339"